Hippocampal Temporal Interference Stimulation for Memory and Posture in Older Adults with Mild Cognitive Impairment
Official title: Effects and Underlying Mechanisms of Hippocampal-Targeted Temporal Interference Stimulation on Memory Function and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment
Run by Shanghai University of Sport · NCT07771036 · Data updated 2026-11-12
Researchers test whether a single session of 40 Hz hippocampal temporal interference stimulation can improve memory and dual-task balance in older adults with mild cognitive impairment, compared to sham stimulation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 21 (estimated) |
| Sponsor | Shanghai University of Sport Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | July 30, 2026 |
| Main results expected | July 15, 2027 |
| Study ends | July 30, 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07771036 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 65+ with subjective memory concerns and mild cognitive impairment (not meeting dementia criteria) who can complete assessments and attend three in-lab visits.
✕Probably not a fit
Patients with dementia, significant mobility impairments, or inability to tolerate stimulation may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the immediate effects of a 40 Hz hippocampal temporal interference stimulation on memory performance and dual-task postural control in older adults with MCI. Participants will undergo three laboratory visits over about three weeks, receiving both active and sham stimulation in random order. The trial uses a randomized, sham-controlled design to assess short-term changes in cognitive and motor function. Eligibility includes age 65 or older with subjective memory concerns and objective cognitive impairment but no dementia, as determined by MoCA-BJ and CDR scores. The lead institution is Shanghai University of Sport, with participants recruited at that site.
Why it matters
Potential benefit: If successful, this approach could offer a noninvasive way to support memory and balance in older adults with MCI.
How similar studies have gone: Prior work in noninvasive brain stimulation has shown mixed or variable short-term benefits; this trial tests a novel 40 Hz hippocampal approach in MCI.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. Aged 65 years or older; 2. Presence of subjective memory complaints; 3. Objective cognitive impairment: screened using the Montreal Cognitive Assessment-Bejingversion (MoCA-BJ). The MoCA-BJ total score is 30 points. For individuals with \<12 years ofeducation, 1 point is added to the raw total score (corrected total score capped at 30 points); acorrected total score \<26 points indicates risk of cognitive impairment; 4. Clinical Dementia Rating (CDR) score of 0.5; 5. Does not meet diagnostic criteria for dementia: Mini-Mental State Examination (MMSE) scores\>18 for illiterate individuals, 221 for those with primary school education, and \>25 for those withjunior high school education or above;6. Retains independent activities of daily living (ADL) and is capable of cooperating with allassessments and interventions.
Where it's running
-
Shanghai University of Sport
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Jiaojiao Lü, PhD
- Email: ljj27@163.com
- Phone: +86 18516565889
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rural Veterans and Care Partners Walking Program
A virtual walking program is tested to see if it can help Veterans with mild cognitive impairment and their care partners in rural areas walk more each day.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
See if multimodal biomarkers can map changes from mild cognitive impairment to dementia
This observational study tests whether clinical, blood, and brain-imaging markers can tell apart stages of cognitive decline and predict progression from mild cognitive impairment to dementia in about 600 people.
-
LIFU to Help Sleep and Amyloid Reduction in Older Adults with Cognitive Impairment
A wearable ultrasound device (ATTN201) is being tested to see if it’s safe and easy to use for people 65 and older with mild cognitive impairment and amyloid buildup.
-
Digital STEADI: A home-based digital fall prevention program for older adults
A home-based digital program using AI-driven conversational agents tests if a guided fall-prevention exercise plan can reduce fall risk for older adults with mild cognitive impairment living independently.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.